Page last updated: 2024-08-18

4-butyrolactone and Laryngeal Neoplasms

4-butyrolactone has been researched along with Laryngeal Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hao, J; Huang, H; Liu, C; Liu, H; Lv, Y; Qin, R; Wen, Y; Yang, X	1

Other Studies

1 other study(ies) available for 4-butyrolactone and Laryngeal Neoplasms

Article	Year
Aspernolide A Inhibits the Proliferation of Human Laryngeal Carcinoma Cells through the Mitochondrial Apoptotic and STAT3 Signaling Pathways. Molecules (Basel, Switzerland), 2019, Mar-19, Volume: 24, Issue:6 Topics: 4-Butyrolactone; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Proliferation; Humans; Laryngeal Neoplasms; Membrane Potential, Mitochondrial; Mitochondria; Signal Transduction; STAT3 Transcription Factor	2019

Article

Year

Aspernolide A Inhibits the Proliferation of Human Laryngeal Carcinoma Cells through the Mitochondrial Apoptotic and STAT3 Signaling Pathways.

Molecules (Basel, Switzerland), 2019, Mar-19, Volume: 24, Issue:6

Topics: 4-Butyrolactone; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Proliferation; Humans; Laryngeal Neoplasms; Membrane Potential, Mitochondrial; Mitochondria; Signal Transduction; STAT3 Transcription Factor

2019